These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 9622754)
21. Preparation and characterization of monoclonal antibodies against recombinant human tumor necrosis factor alpha. Li Y; Zhao WW; Shen BF; Sun YX; Wang WX Chin J Biotechnol; 1991; 7(2):121-6. PubMed ID: 1806022 [TBL] [Abstract][Full Text] [Related]
22. Effect of experimentally induced endotoxemia on serum interleukin-6 activity in horses. Morris DD; Moore JN; Crowe N; Moldawer LL Am J Vet Res; 1992 May; 53(5):753-6. PubMed ID: 1524301 [TBL] [Abstract][Full Text] [Related]
23. Endotoxin induced expression of tumour necrosis factor, tissue factor and plasminogen activator inhibitor activity by peritoneal macrophages. Barton MH; Collatos C; Moore JN Equine Vet J; 1996 Sep; 28(5):382-9. PubMed ID: 8894536 [TBL] [Abstract][Full Text] [Related]
24. Effects of lidocaine infusion during experimental endotoxemia in horses. Peiró JR; Barnabé PA; Cadioli FA; Cunha FQ; Lima VM; Mendonça VH; Santana AE; Malheiros EB; Perri SH; Valadão CA J Vet Intern Med; 2010; 24(4):940-8. PubMed ID: 20649751 [TBL] [Abstract][Full Text] [Related]
25. Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo. Asher A; Mulé JJ; Reichert CM; Shiloni E; Rosenberg SA J Immunol; 1987 Feb; 138(3):963-74. PubMed ID: 3805720 [TBL] [Abstract][Full Text] [Related]
26. Failure to inhibit endotoxin-induced uveitis with antibodies that neutralize tumor necrosis factor. Rosenbaum JT; Boney RS Reg Immunol; 1993; 5(5):299-303. PubMed ID: 8148240 [TBL] [Abstract][Full Text] [Related]
27. Induction of the acute-phase cytokine, hepatocyte-stimulating factor/interleukin 6, in the circulation of horses treated with endotoxin. MacKay RJ; Lester GD Am J Vet Res; 1992 Aug; 53(8):1285-9. PubMed ID: 1510298 [TBL] [Abstract][Full Text] [Related]
28. Effects of subanesthetic doses of ketamine on hemodynamic and immunologic variables in dogs with experimentally induced endotoxemia. DeClue AE; Cohn LA; Lechner ES; Bryan ME; Dodam JR Am J Vet Res; 2008 Feb; 69(2):228-32. PubMed ID: 18241020 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of digital and laminar blood flow in horses given a low dose of endotoxin. Ingle-Fehr JE; Baxter GM Am J Vet Res; 1998 Feb; 59(2):192-6. PubMed ID: 9492935 [TBL] [Abstract][Full Text] [Related]
30. Pentoxifylline inhibits mediator synthesis in an equine in vitro whole blood model of endotoxemia. Barton MH; Moore JN Circ Shock; 1994 Dec; 44(4):216-20. PubMed ID: 7628064 [TBL] [Abstract][Full Text] [Related]
31. Depletion of pulmonary intravascular macrophages partially inhibits lipopolysaccharide-induced lung inflammation in horses. Parbhakar OP; Duke T; Townsend HG; Singh B Vet Res; 2005; 36(4):557-69. PubMed ID: 15955281 [TBL] [Abstract][Full Text] [Related]
32. Effect of alcohol on the secretion of tumor necrosis factor-alpha by macrophages in the presence of rat serum. Nakatani Y; Fukui H; Kitazawa T; Fujimoto M; Yamao J; Uemura M Alcohol Clin Exp Res; 2002 Aug; 26(8 Suppl):81S-85S. PubMed ID: 12198381 [TBL] [Abstract][Full Text] [Related]
33. Induction of early-phase endotoxin tolerance in horses. Allen GK; Campbell-Beggs C; Robinson JA; Johnson PJ; Green EM Equine Vet J; 1996 Jul; 28(4):269-74. PubMed ID: 8818592 [TBL] [Abstract][Full Text] [Related]
34. Preventive effects of a biscoclaurine alkaloid, cepharanthine, on endotoxin or tumor necrosis factor-alpha-induced septic shock symptoms: involvement of from cell death in L929 cells and nitric oxide production in raw 264.7 cells. Sakaguchi S; Furusawa S; Wu J; Nagata K Int Immunopharmacol; 2007 Feb; 7(2):191-7. PubMed ID: 17178386 [TBL] [Abstract][Full Text] [Related]
35. The tumor necrosis factor alpha -308 G/A polymorphism does not influence inflammation and coagulation response in human endotoxemia. Kovar FM; Marsik C; Cvitko T; Wagner OF; Jilma B; Endler G Shock; 2007 Mar; 27(3):238-41. PubMed ID: 17304103 [TBL] [Abstract][Full Text] [Related]
36. Role of tumour necrosis factor in the enhanced sensitivity of mice to endotoxin after exposure to lead. Dentener MA; Greve JW; Maessen JG; Buurman WA Immunopharmacol Immunotoxicol; 1989; 11(2-3):321-34. PubMed ID: 2621320 [TBL] [Abstract][Full Text] [Related]
37. Effects of polymyxin B and Salmonella typhimurium antiserum on horses given endotoxin intravenously. Durando MM; MacKay RJ; Linda S; Skelley LA Am J Vet Res; 1994 Jul; 55(7):921-7. PubMed ID: 7978630 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of polymyxin B in an ex vivo model of endotoxemia in horses. Parviainen AK; Barton MH; Norton NN Am J Vet Res; 2001 Jan; 62(1):72-6. PubMed ID: 11197565 [TBL] [Abstract][Full Text] [Related]
39. Interleukin-6 infusion during human endotoxaemia inhibits in vitro release of the urokinase receptor from peripheral blood mononuclear cells. Ostrowski SR; Plomgaard P; Fischer CP; Steensberg AS; Møller K; Høyer-Hansen G; Pedersen BK; Ullum H Scand J Immunol; 2005 Feb; 61(2):197-206. PubMed ID: 15683457 [TBL] [Abstract][Full Text] [Related]
40. Prevention of human TNF-induced cutaneous Shwartzmann reaction and acute mortality in mice treated with anti-human TNF monoclonal antibodies. Grau GE; Vesin C; De Groote D; Delacroix D; Gysler C; Piguet PF; Lambert PH Clin Exp Immunol; 1991 Jun; 84(3):411-4. PubMed ID: 2044219 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]